Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Louise S. Perez is active.

Publication


Featured researches published by Louise S. Perez.


Circulation | 1998

PDGF-Receptor Tyrosine Kinase Blocker AG1295 Selectively Attenuates Smooth Muscle Cell Growth In Vitro and Reduces Neointimal Formation After Balloon Angioplasty in Swine

Shmuel Banai; Yehuda G. Wolf; Gershon Golomb; Andrew Pearle; Johannes Waltenberger; Ilia Fishbein; Aviva Schneider; Aviv Gazit; Louise S. Perez; Rita Huber; Galila Lazarovichi; Laura Rabinovich; Alexander Levitzki; S. David Gertz

BACKGROUND Signaling through protein tyrosine kinases (PTKs) is a major contributor to the transmission of mitogenic stimuli to the interior of the cell and nucleus. The present study was designed to determine the effect of the tyrphostin AG1295, a selective blocker of PDGF-receptor PTK, on the growth of porcine and human smooth muscle cells (SMCs) in culture, on the outgrowth kinetics of SMCs from porcine and human arterial explants, and on neointimal formation after balloon injury in pigs. METHODS AND RESULTS SMCs for culture were obtained from porcine abdominal aortas, human internal mammary arteries, and endarterectomy tissue from a single human carotid artery. Addition of AG1295 to SMCs before PDGF stimulation completely inhibited PDGF-beta-receptor tyrosine phosphorylation without affecting the level of PDGF-beta-receptor. AG1295 resulted in a selective, reversible inhibition of SMC proliferation in culture (76%) with only mild (13.5%) inhibition of endothelial cell proliferation. The number of SMCs accumulating around explants of porcine carotid arteries and human endarterectomy specimens 12, 15, 19, 22, and 24 days after plating was reduced by 82% to 92% in AG1295-treated compared with nontreated specimens, and initiation of SMC outgrowth was markedly delayed. The numbers of cells accumulated 10 days after initiation of outgrowth were significantly lower in treated versus control explants. Local intravascular delivery of AG1295-impregnated polylactic acid-based nanoparticles (130+/-25 nm) to the site of balloon injury to porcine femoral arteries resulted in significant reductions in intima/media area ratio and luminal cross-sectional area narrowing by neointima compared with contralateral control arteries to which empty nanoparticles were applied (0.15+/-0.07 versus 0.09+/-0.03, P=.046 and 20+/-4% versus 10+/-4%, P=.0009, n=6 for both). CONCLUSIONS The tyrphostin AG1295, a selective blocker of PDGF-receptor kinase, exerts a marked inhibitory effect on the activation, migration, and proliferation of porcine and human SMCs in vitro and an approximately 50% inhibitory effect on neointimal formation after balloon injury in porcine femoral arteries when delivered via biodegradable nanoparticles. Further studies appear to be warranted to evaluate the applicability of this novel approach to the interventional setting.


Lasers in Surgery and Medicine | 2008

Irradiation with 780 nm diode laser attenuates inflammatory cytokines but upregulates nitric oxide in lipopolysaccharide-stimulated macrophages: implications for the prevention of aneurysm progression.

Lilach Gavish; Louise S. Perez; Petachia Reissman; S. David Gertz

Low level laser irradiation (LLLI) has been shown to reduce inflammation in a variety of clinical situations. We have shown that LLLI (780 nm) increases aortic smooth muscle cell proliferation and matrix protein secretion and modulates activity and expression of matrix metalloproteinases. Inflammation is a major component of arteriosclerotic diseases including aneurysm. Macrophage recruitment and secretion of pro‐inflammatory cytokines and the vasodilator, nitric oxide (NO), are central to most immune responses in the arterial wall. The present study was designed to determine the effect of LLLI on cytokine gene expression and secretion as well as gene expression of inducible nitric oxide synthase (iNOS) and NO production in lipopolysaccharide (LPS)‐stimulated macrophages.


Circulation | 1994

Geometric remodeling is not the principal pathogenetic process in restenosis after balloon angioplasty. Evidence from correlative angiographic-histomorphometric studies of atherosclerotic arteries in rabbits.

S D Gertz; L W Gimple; Shmuel Banai; M Ragosta; E R Powers; W C Roberts; Louise S. Perez; I J Sarembock

BackgroundRestenosis after balloon angioplasty of coronary arteries is thought to be a proliferative response of the arterial wall to injury. Recently, it has been suggested that geometric remodeling of the arterial wall, rather than intimal fibromuscular hyperplasia, may be the major pathophysiological mechanism underlying restenosis. In this study, we evaluated the relative contribution of a geometric decrease in arterial size versus neointimal growth to luminal narrowing associated with restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Methods and ResultsFocal femoral atherosclerosis was induced by endothelial desiccation injury followed by a 2% cholesterol diet. After 1 month on the high cholesterol diet, the animals were subjected to one of four strategies: (1) balloon angioplasty, (2) balloon angioplasty followed by treatment with the factor Xa inhibitor antistasin, (3) combined laser and balloon angioplasty, or (4) no angioplasty. Animals were killed 2 hours or 28 days after angioplasty, and excised femoral artery segments were prepared for histomorphometric analysis. Angiography was performed serially before and immediately after angioplasty and before the animals were killed. An initial postprocedural gain in luminal diameter at sites of angioplasty was followed by a significant reduction in diameter by angiography and a significant increase in luminal cross-sectional area narrowing by plaque by histomorphometry 28 days after angioplasty compared to adjacent nonangioplastied segments of the same arteries, to nonangioplastied control arteries, or to angioplastied segments of animals treated with the factor Xa inhibitor antistasin. By contrast, the overall arterial size (cross-sectional area bounded by the external elastic lamina) at sites of restenosis was not significantly different from adjacent nonangioplastied segments in the majority of arteries excised at 28 days, and the mean overall arterial size at sites of restenosis was not significantly different from corresponding segments of nonangioplastied control arteries or from angioplastied segments of animals treated with antistasin. In the minority of angioplastied arteries in which the arterial size did change, most got larger. ConclusionsGeometric remodeling resulting in a decrease in overall cross-sectional arterial size does not appear to be the principal pathogenetic mechanism for restenosis after balloon angioplasty with or without laser in this experimental model.


Atherosclerosis | 2002

Metalloproteinase inhibitor attenuates neointima formation and constrictive remodeling after angioplasty in rats: augmentative effect of αvβ3 receptor blockade

Leon Margolin; Ilia Fishbein; Shmuel Banai; Gershon Golomb; Reuven Reich; Louise S. Perez; S. David Gertz

Abstract Release of matrix metalloproteinases (MMP) from smooth muscle and foam cells following arterial injury facilitates cell migration, neointimal hyperplasia, and vessel wall remodeling. Inhibition of MMP activity using the hydroxamate, zinc-chelating mimicers of collagen, Batimastat and Marimastat, has shown efficacy in reducing constrictive vascular remodeling 6 weeks after experimental angioplasty but not intimal hyperplasia. Vitronectin receptor (α v β 3 ) blockade interferes with binding of this integrin to MMP-2 and proteolyzed collagen, thereby reducing cell invasion. This study tests the effect of MMP inhibition, with and without vitronectin receptor (α v β 3 ) blockade, on neointima formation and arterial remodeling in a long-term model (up to 212 months) of balloon injury in vivo. Male Sabra rats were treated with Batimastat (BB-94, British Biotech Pharmaceuticals Ltd., 30 mg/kg, intraperitoneally) and/or the α v β 3 receptor inhibiting RGD peptide, G-Pen-GRGDSPCA (GIBCO BRL, 0.1 μmol), administered as a perivascular gel to the common carotid artery after balloon injury. Animals were sacrificed 3, 14, 25, and 75 days ( n =21, 23, 22, and 21) after injury. Animals treated with BB-94, peptide, or both had markedly increased absolute luminal area with markedly reduced luminal cross-sectional-area narrowing by neointima and intima-to-media area ratio at all time points except for 3 days after balloon injury versus non-treated, ballooned animals. Combined treatment was significantly more effective than either one alone. Constrictive remodeling, most marked 212 months after balloon injury, was prevented at this time point in all treated animals. The pattern of reduction in luminal narrowing, neointimal formation, and constrictive remodeling across treatment groups correlated very significantly with the reduction in tissue MMP activity as determined by zymography at 3 days. Confirmation of the efficacy of this strategy in larger animals should be the next step toward testing the applicability of this novel approach to the interventional setting.


Cardiovascular Research | 1997

Predictors of luminal narrowing by neointima after angioplasty in atherosclerotic rabbits

S. David Gertz; William L. Barry; Lawrence W. Gimple; Shmuel Banai; Louise S. Perez; Coleen A. McNamara; Eric R. Powers; Michael Ragosta; Gary K. Owens; William C. Roberts; Ian J. Sarembock

OBJECTIVE The present study was designed to identify the predictors of cross-sectional area narrowing by neointima (%CSAN-N) after balloon angioplasty (BA) in the cholesterol fed rabbit model. METHODS Angiographic, histomorphometric, and immunohistochemical data were analyzed from 91 femoral arteries of New Zealand white rabbits. Focal atherosclerosis was induced by air desiccation of the endothelium followed by a 2% cholesterol diet for 28 days. The rabbits received heparin (150 U/kg) at the time of BA (2.5 mm; three, 60-second, 10-atm inflations). Arteries were perfusion-fixed and excised 7 (n = 16), 14 (n = 11), 21 (n = 9), or 28 (n = 20) days after BA. Non-angioplastied arteries were de-endothelialized (cholesterol-fed [n = 12] or normal diet [n = 8]), non-injured but cholesterol-fed (n = 7), or normal (n = 8). RESULTS Univariate regression across all groups showed that the absolute area of the lumen by histomorphometry (LA) correlated significantly with the area bounded by the external elastic lamina (EEL) (vessel size), but no correlation was found with the absolute area of neointima or media, the percentage disruption of the internal elastic lamina (IEL), or the percentage of neointima and media occupied by foam cells. However, %CSAN-N correlated significantly with the area bounded by the EEL, significantly with the absolute neointimal area, and negatively with the absolute LA (p < 0.0001). Significant correlations were also found between %CSAN-N and the % IEL disrupted, the area of neointima and media occupied by RAM-11 + foam cells, and the loss of alpha-actin positivity in the media (p < 0.0001). CONCLUSIONS These studies show that neointimal formation contributes significantly to luminal narrowing 1 month after angioplasty in this model, that the degree of vascular injury and the extent of foam cell accumulation in the neointima and media are significant independent predictors of neointimal formation, and that the area of the neointima, and the percent narrowing by neointima, are important predictors of remodeling itself (EEL area). These predictors were not identifiable when the analysis was focused on the determinants of absolute luminal area alone.


Archive | 2008

Irradiation with 780 nm Diode Laser Attenuates Inflammatory Cytokines While Upregulating Nitric Oxide in LPS-Stimulated Macrophages: Implications for the Prevention of Aneurysm Progression

Lilach Gavish; Louise S. Perez; Petachia Reissman; S. David Gertz

Low level laser irradiation (LLLI) has been shown to reduce inflammation of tissue and we show that 780 nm radiation modifies certain processes fundamental to aneurysm progression. This study has been designed to determine the effect of LLLI on cytokine gene expression and secretion of inductible nitric oxide synthase (iNOS) and NO production in lipopolysaccharide (LPS) - stimulated macrophages.


Lasers in Surgery and Medicine | 2006

Low-level laser irradiation modulates matrix metalloproteinase activity and gene expression in porcine aortic smooth muscle cells

Lilach Gavish; Louise S. Perez; S. David Gertz


Biomaterials | 2005

Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries

Shmuel Banai; Michael Chorny; S. David Gertz; Ilia Fishbein; Jianchuan Gao; Louise S. Perez; Galila Lazarovichi; Aviv Gazit; Alexander Levitzki; Gershon Golomb


Cardiovascular Research | 2004

Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries

Shmuel Banai; S. David Gertz; Lilach Gavish; Michael Chorny; Louise S. Perez; Galila Lazarovichi; Mickey Ianculuvich; Michael Hoffmann; Michael Orlowski; Gershon Golomb; Alexander Levitzki


Experimental and Molecular Pathology | 1993

Response of femoral arteries of cholesterol-fed rabbits to balloon angioplasty with or without laser: emphasis on the distribution of foam cells.

S.David Gertz; Lawrence W. Gimple; Michael Ragosta; William C. Roberts; Howard L. Haber; Eric R. Powers; Louise S. Perez; Ian J. Sarembock

Collaboration


Dive into the Louise S. Perez's collaboration.

Top Co-Authors

Avatar

S. David Gertz

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Shmuel Banai

Tel Aviv Sourasky Medical Center

View shared research outputs
Top Co-Authors

Avatar

Gershon Golomb

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Alexander Levitzki

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Lilach Gavish

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Aviv Gazit

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Galila Lazarovichi

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Eric R. Powers

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge